Prognosis and Course of COVID-19 Infection in Hospitalised Patients

CompletedOBSERVATIONAL

Enrollment

345

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

March 1, 2021

Study Completion Date

January 10, 2023

Conditions

Covid19SARS-CoV Infection

Interventions

DIAGNOSTIC_TEST

Chitotriosidase activity

The chitotriosidase activity will be measured in all the subjects

Trial Locations (2)

University Hospital #1, Moscow

University Hospital #4, Moscow

All Listed Sponsors

lead

I.M. Sechenov First Moscow State Medical University

OTHER

NCT04752085 - Prognosis and Course of COVID-19 Infection in Hospitalised Patients | Biotech Hunter | Biotech Hunter